← Case Library

Clause 11.2

⚖ 14 PMCPA cases 🔒 Members see all 14 cases

PMCPA Cases — Clause 11.2

14 cases
📅 8 Mar 2026 · AstraZeneca

AstraZeneca: LinkedIn post and Sunday Times interview found to promote Enhertu for an unlicensed indication (AUTH/3561/9/21)

Clause 11.2 Clause 2 Clause 26.1 Clause 26.2 +3 more
📅 8 Mar 2026 · Novo Nordisk

Novo Nordisk breached ABPI Code over Saxenda leavepiece: missing ‘stopping rule’, PI inconsistency and 0845 AE reporting number (AUTH/3737/2/23)

Clause 11.2 Clause 12.1 Clause 5.1
📅 8 Mar 2026 · AstraZeneca

AstraZeneca breached ABPI Code over Forxiga “start on 10mg” dosing claims hidden behind footnote (AUTH/3618/3/22)

Clause 11.2 Clause 14.4 Clause 2 Clause 5.1 +2 more
🔒

See all 14 cases for Clause 11.2

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

Already a member? Sign in

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free